Correction to: Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin

Detalles Bibliográficos
Autores principales: Hayashi, Toshiyuki, Fukui, Tomoyasu, Nakanishi, Noriko, Yamamoto, Saki, Tomoyasu, Masako, Osamura, Anna, Ohara, Makoto, Yamamoto, Takeshi, Ito, Yasuki, Hirano, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683452/
https://www.ncbi.nlm.nih.gov/pubmed/29132354
http://dx.doi.org/10.1186/s12933-017-0608-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683452/
https://www.ncbi.nlm.nih.gov/pubmed/29132354
http://dx.doi.org/10.1186/s12933-017-0608-5

Ejemplares similares